Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4860-4866

  Imoto, Issei ^a   Tsuda, Hitoshi ^b   Hirasawa, Akira ^a   Miura, Masahiko ^a   Sakamoto, Masaru ^c   Hirohashi, Setsuo ^d   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c SASAKI INSTITUTE   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN; PROTEIN CIAP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 11Q; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROTEIN BIOSYNTHESIS; PROTEINS; RADIATION TOLERANCE; SURVIVAL RATE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0036733756     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Cancer of the uterine cervix
2. Chromosome 6p21.2, 18q21.2, and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy
3. The molecular genetics of cervical carcinoma
4. Oncogene amplification in solid tumors
5. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix
6. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix
7. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines
8. Clinical implications of the epidermal growth factor receptor in squamous cell carcinoma of the uterine cervix
9. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
10. DNA copy number losses in human neoplasms
11. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q
12. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma
13. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas
14. ASTRO Research Fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma
15. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma
16. The role of apoptosis in gynaecological malignancies
17. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: Correlations with clinical outcome
18. Tumor apoptosis in cervical cancer: Its role as a prognostic factor in 42 radiotherapy patients
19. Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma
20. High dose rate brachytherapy for carcinoma of the uterine cervix: Comparison of two different fractionation regimens
21. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumor suppressor gene of renal cell carcinoma by three-color fluorescent in situ hybridization
22. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines
23. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer
24. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients
25. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
26. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias
27. Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins
28. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-κB signal pathway
29. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis
30. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
31. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
32. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy
33. Inhibitor of apoptosis proteins in prostate cancer cell lines
34. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients
35. High levels of expression and nuclear localization of interleukin-1 β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas
36. Nuclear localization of procaspase-9 and processing by a caspase-3-like activity in mammary epithelial cells
37. X-linked IAP is a direct inhibitor of cell-death proteases
38. The c-IAP-1 and c-IAP-2 proteins are distinct inhibitors of specific caspases
39. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
40. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
41. Identification of XAF1 as an antagonist of XIAP anti-caspase activity